Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Viking Therapeutics (VKTX) Return on Assets (2016 - 2026)

Viking Therapeutics (VKTX) has disclosed Return on Assets for 12 consecutive years, with 0.71% as the latest value for Q1 2026.

  • For Q1 2026, Return on Assets fell 57.0% year-over-year to 0.71%; the TTM value through Mar 2026 reached 0.71%, down 57.0%, while the annual FY2025 figure was 0.44%, 27.0% down from the prior year.
  • Return on Assets hit 0.71% in Q1 2026 for Viking Therapeutics, down from 0.49% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.1% in Q2 2024 and bottomed at 0.71% in Q1 2026.
  • Average Return on Assets over 5 years is 0.28%, with a median of 0.27% recorded in 2023.
  • Year-over-year, Return on Assets soared 31bps in 2024 and then tumbled -57bps in 2026.
  • Viking Therapeutics' Return on Assets stood at 0.41% in 2022, then surged by 44bps to 0.23% in 2023, then skyrocketed by 48bps to 0.12% in 2024, then crashed by -315bps to 0.49% in 2025, then plummeted by -44bps to 0.71% in 2026.
  • According to Business Quant data, Return on Assets over the past three periods came in at 0.71%, 0.49%, and 0.3% for Q1 2026, Q4 2025, and Q3 2025 respectively.